|
⚲
|
| Keyboard |
| Linden Advisors LP | |
|---|---|
| Firm | Linden Advisors LP |
| Address | 590 Madison Avenue 32nd Floor New York, NY 10022 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Linden Advisors LP | |||||
| Linden Capital LP | 021-128519 | Promoter | 781.9 M | 37.22 B | |
| Linden Investors LP | 021-71674 | Promoter | 2,464.7 M | ||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tetralogic Pharmaceuticals Corp TLOG
8% Senior Convertible Notes due 2024 · derivative
|
2016-11-14 | Other | |||
|
Tetralogic Pharmaceuticals Corp TLOG
Preferred Stock · derivative
|
2016-11-14 | Other | |||
|
Tetralogic Pharmaceuticals Corp TLOG
8% Senior Convertible Notes due 2019 · derivative
|
2016-11-14 | Other | 2,095,239 |